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ABSTRACT: With the COVID-19 pandemic, the evolutionary fate of SARS-CoV-
2 becomes a matter of utmost concern. Mutation D614G in the spike (S) protein
has become dominant, and recent evidence suggests it yields a more stable
phenotype with higher transmission efficacy. We carry out a structural analysis that
provides mechanistic clues on the enhanced infectivity. The D614G substitution
creates a sticky packing defect in subunit S1, promoting its association with subunit
S2 as a means to stabilize the structure of S1 within the S1/S2 complex. The results
raise the therapeutic possibility of immunologically targeting the epitope involved
in stabilizing the G614 phenotype as a means of reducing the infection efficacy of
SARS-CoV-2. This therapeutic modality would not a-priori interfere directly with
current efforts toward the immunological targeting of the RBD epitope; hence, it
could be exploited as a complementary treatment.
The virus SARS-CoV-2 arose in China and rapidlypropagated leading to the COVID-19 pandemic of 2020.
With the awareness of this public health disaster, the
evolutionary fate of the virus becomes a matter of the utmost
concern.1−4 Its evolutionary change is likely to impact key
functionalities associated with transmission efficacy and severity,
bearing directly on the course of the pandemic.
Korber et al.1 provided epidemiological evidence that the
amino acid substitution D614G in SARS-CoV-2 spike protein is
rapidly becoming dominant, suggesting that the G614 mutant
may entail a significant fitness advantage. Since the spike (S)
protein mediates the viral recognition of the host receptor
(angiotensin-converting enzyme 2, hACE2) as well as the fusion
of viral and cellular membrane, it becomes imperative to find out
how this mutation affects viral transmission and infectivity.
Korber et al.1 argued that the rapid spread of the G614 mutant is
related to higher infectivity. To support this hypothesis, they
showed that the G614 variant yields higher titers in
pseudoviruses from in vitro experiments. These results appear
to be corroborated by other groups.2,3 In infected individuals,
the variant G614 is likely to cause higher upper respiratory tract
viral loads, yet the severity of the disease does not appear to
increase. These findings prompt a mechanistic assessment of the
impact of the S-protein mutation on virus transmission as a
guidance to steer the development of novel immunological
cures.
■ TRANSMISSION EFFICACY OF SARS-COV-2 G614
VARIANT
The two competing phenotypes SD614 and SG614 were recently
characterized and compared by Zhang et al.4 Their analysis
revealed that retroviruses pseudotyped with SG614 infected
hACE2-expressing cells significantly more efficiently than those
with SD614. To interpret the results, we first note that the S
protein is organized as a trimer with each monomer containing
two tethered and mutually interacting domains S1 and S2, the
first involved in receptor binding (RB) through its RBD domain,
while S2 mediates the fusion of viral and cellular membranes.1
The greater transmission efficiency of the G614 mutant was
proven not to correlate with higher epitope affinity or binding
efficacy but with less S1 shedding and greater incorporation of
the S protein into the pseudovirion, pointing to a higher stability
of the SG614 phenotype.4 Because S1 residue 614 is proximal to
the S2 domain in the S-protein quaternary structure, Zhang et
al.4 first compared the ratio between the S1 and S2 domains in
the virion that might signal altered release or shedding of the S1
domain after cleavage at the S1/S2 junction. The resulting S1:S2
ratio is markedly greater in PVG614 compared with PVD614,
implying that G614 stabilizes the interaction between the S1 and
S2 domains, which limits S1 shedding.
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■ STRUCTURAL AND MECHANISTIC IMPACT OF THE
D614G MUTATION
A biophysical/structural analysis of the impact of the D614G
substitution on the S1/S2 interface supports this picture, yet as
shown subsequently, the analysis needs to go beyond mere
structural considerations (cf. ref 1) and incorporate the
relationship between structure and enveloping solvent, the so-
called epistructure.5 It has been postulated1 that the carboxyl
group in D614 forms a hydrogen bond with the hydroxyl group
in T859 across the S1/S2 interface. The crystal structures of the
complex do not support this picture, since the side-chain groups
are not properly oriented for hydrogen bonding (Figure 1a).
Furthermore, this conjecture is completely at odds with the
experimental results of Zhang et al.4 because the substitution
D614G would eliminate altogether the postulated hydrogen
bond across the S1/S2 interface; hence, the SG614 phenotype
would be characterized by more S1 shedding compared with
SD614. The experimental evidence favors precisely the opposite
conclusion.4
A more thorough analysis of the impact of the D614G
substitution takes into account the epistructure of the
interacting S1 and S2 domains. The preformed D614-A647
backbone hydrogen bond (BHB) is partially exposed to the
solvent (Figure 1b), and hence it constitutes a special kind of
packing defect known as dehydron5−7 in the S1 domain. From a
thermodynamic standpoint, the dehydron is an adhesive spot
promoting removal of surrounding water7,8 for two mutually
reinforcing reasons:5−7 (a) the preformed BHB gets stabilized
when a protein association (i.e., S1/S2 interaction) causes
Figure 1. Structural and epistructural interactions at the S1/S2 interface in the spike protein of SARS-CoV-2. (a) Positioning of D614 in the S1 chain
(magenta) relative to T859 in the S2 chain (blue) at the S1/S2 interface for the spike protein structure reported in PDB6VXX. The protein backbone is
rendered in ribbon representation. (b) Intramolecular wrapping of backbone hydrogen bonds (BHBs) around dehydron D614-A647 for the S1 chain.
The protein backbone is represented as a polygonal (magenta) with lines joining the α-carbons of consecutive residues. Well wrapped BHBs are shown
as gray lines joining α-carbons of paired residues, while the dehydron is shown in green. The wrapping of each BHB is indicated by thin blue lines from
the center of the bond to the α-carbon of the residue that contributes side-chain nonpolar groups to the desolvation domain of the BHB. The ribbon
rendering is an aid to the eye. (c) Improved intramolecular wrapping of dehydron D614-A647 achieved by forming the D614-R646 salt bridge. In this
configuration, R646 contributes two extra side-chain methylene groups (asterisks) to the wrapping of the D614-A647 BHB when compared with the
fully hydrated R646 side chain that occurs when S1 becomes part of the S1/S2 complex (inset). (d) Intermolecular wrapping of dehydron D614-A647
by P862 across the S1/S2 interface. The chains are labeled A and B, corresponding respectively to S1 and S2, as reported in PDB 6VXX.
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removal of surrounding water thereby hindering the structurally
disruptive hydration of amide and carbonyl (destabilizing the
unbound state is tantamount to stabilize the bound state), and
(b) the removal of backbone-solvating water molecules at the
dehydron site is favorable because the partial confinement of
such water molecules curtails their hydrogen bonding
coordination possibilities; therefore, their transference to the
bulk becomes thermodynamically supported.8 The dehydron
adhesiveness can also be justified from an energetic standpoint,
as the screening of partial charges paired by the BHB is removed
concurrently with the removal of surrounding water molecules,
thus strengthening the BHB.7
In general, dehydrons compromise the integrity of the protein
structure, exposing it to disruptive backbone hydration, and
promote protein associations as a means to exclude surrounding
water.5−7 In this way, dehydrons become determinants for
protein association because, by decreasing charge screening,
exogenous removal of water from the dehydron microenviron-
ment strengthens and stabilizes the electrostatic interaction that
underlies the BHB. Bioinformatics evidence on the distribution
of dehydrons at interfaces of protein complexes supports this
picture, pointing to dehydrons as important factors driving
complex formation.7
To identify dehydrons in the protein structure, we have
introduced a descriptor named wrapping that determines the
reliance on binding partnerships to maintain local structural
integrity.6,7 A dehydron is then an underwrapped BHB which
possesses an insufficient number of side-chain nonpolar groups
clustered around the BHB, so that the BHB is exposed to
structure-disruptive hydration. Dehydrons and wrappingmay be
computed directly from structural coordinates.7 The extent of
hydrogen-bond wrapping gives the number of side chain
nonpolar groups contained within a ‘“desolvation domain”’
(two intersecting balls centered at the α-carbons of the paired
residues) that defines the BHB microenvironment in a reported
structure. Thus, dehydrons are located in the tail of the
distribution of wrapping values across BHBs in a structural
database (Methods).7
In our case, the D614-A647 BHB in domain S1 is a dehydron
wrapped intramolecularly by residues D614, A647, V615, T645,
and R646 (Figure 1b). It achieves maximum wrapping from
R646 when this residue forms a salt bridge with D614 (Figure
1c). In this way, the salt bridge D614-R646 contributes to
stabilize BHB D614-A647 in the uncomplexed S1, while also
blocking the S1/S2 association. As S1 gets associated with S2,
the salt bridge gets dismantled (it is not present, as expected, in
PDB structure 6VXX) and the dehydron D614-A647 completes
its wrapping intermolecularly with a contribuition from P862
from the S2 domain (Figure 1d). The substitution D614G has a
major impact on the epistructure of S1, vis-a-̀vis the previous
considerations. The effect results from two contributions: (a)
MutationD614G eliminates the salt bridge that hampers the S1/
S2 association as it improves the wrapping of the dehydron
pairing residues at locations 614 and 647. (b) By reducing the
dehydron-wrapping contributions from side chains at positions
614 and 646, the mutation destabilizes the uncomplexed S1
domain, making the dehydron G614-A647 a better promoter of
the S1/S2 association. In the G614 mutant, the 614-647 BHB
becomesmore reliant on the contribution from P862 that occurs
upon S1/S2 association (Figure 1d) to maintain its structural
integrity.
In other words, the D614G mutation promotes the S1/S2
association because (a) it destabilizes the free (uncomplexed)
S1 structure through the enhanced exposure of the BHB pairing
residues G614 and A647 and (b) it stabilizes the S1/S2 interface
as the D614G substitution decreases the intramolecular
wrapping of the G614-A647 dehydron, thereby further
promoting its intermolecular wrapping via the contribution
from S2 residue P862 (Figure 1d). A conservative estimate
drawn from experimental data on the cost of unwrapping the
BHB (ref 8 Figure 3) gives 3 × 8 kJ/mol = 5.73 kcal/mol as the
thermodynamic cost of destabilizing the S1 structure resulting
from depriving the BHB 614−647 of three wrapping carbona-
ceous groups due to the D614G substitution. The lost wrapping
contributions include one methylene group from the D → G
substitution proper and two methylene groups from R646 that
no longer can form the salt bridge with the glycine at position
614 (cf. Figure 1c).
Thus, the net gain in stability (loss in free energy) for the S1/
S2 complex resulting from the D614G mutation is significant
and may be conservatively estimated at ΔΔG = −5.73kcal/mol.
We emphasize that the stabilization of the S1/S2 complex arises
from the destabilization of the free (uncomplexed) S1 structure.
■ CONCLUSIONS AND DISCUSSION
The structural, or rather epistructural, impact of the mutation
D614G is consistent with established phenotypic differences
between SG614 and SD614 in the sense that SG614 has a greater
stability resulting from less S1 shedding and greater incorpo-
ration of the intact S protein into the pseudovirion.4 In this way,
the epistructural analysis sheds light on the mechanistic
underpinnings for the superior transmission efficiency of the
G614 strain of SARS-CoV-2.
The epistructural analysis presented raises the enticing
therapeutic possibility of immunologically targeting the epitope
involved in reducing S1-shedding as a means of impairing the
infection efficacy of the G614 strain. Thus, a monoclonal
antibody targeting the epitope associated with the dehydron
614-647 (Figure 1c) could significantly promote S1 shedding
and destabilize the SG614 phenotype to levels representing severe
impairment of the viral infectivity. This therapeutic modality
would not a-priori interfere directly with current efforts toward
an immunological targeting of the RBD epitope, hence it could
serve as a complementary treatment.
■ METHODS
Dehydrons were identified from PDB-reported structural coordinates
of proteins5−8 using a plugin to the PyMol platform (https://
pymolwiki.org/index.php/Dehydron). To that end, we define the
extent of hydrogen-bond wrapping, w, giving the number of side chain
nonpolar groups (CHn, n = 1, 2, 3) contained within a ‘“desolvation
domain”’ around the BHB. The desolvation domain is defined as two
intersecting balls of fixed radius commensurate with three water layers
centered at the α-carbons of the residues paired by the BHB. A
wrapping analysis of nonredundant 7476 high quality X-ray structures
deposited in PDB was performed adopting the desolvation radius 6.5 Å
(code publicly available at https://raw.githubusercontent.com/Pymol-
Scripts/Pymol-script-repo/master/plugins/dehydron.py). The results
revealed that backbone hydrogen bonds are wrapped by w = 27.41 ±
8.07 nonpolar groups. Being marginally wrapped, dehydrons are
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